Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Damage to nerves during surgery or after an injury can lead to long-term pain. Scientists have found that specialised cells help to remove damaged nerve fibres, allowing new healthy nerves to re-grow, ameliorating nerve pain.

© Alexander Davies
Natural Killer cells invading a damaged nerve
‘If we can tailor current treatments to help the Natural Killer cells remove damaged nerves we may have a way to speed the recovery from a painful nerve injury without the narcotic side-effects of other pain killers. - Alexander Davies

It is already known that Natural Killer cells play an important role in fighting cancer, in both mice and humans. In some cancer treatments, their function is enhanced by using drugs to make the cells more active.

In this new pain research, led by Alexander Davies and Simon Rinaldi, and funded by the National Research Council of Korea, the MRC, NIH and ERC, the team used a similar approach to make the Natural Killer cells more effective in removing damaged nerve fibres in mice. They showed that better removal of these damaged fibres reduced the hypersensitivity associated with chronic nerve pain.

Read more on the University of Oxford website

Similar stories

Attention and memory deficits persist for months after recovery from mild COVID

Researchers from Oxford’s Nuffield Department of Clinical Neurosciences and Department of Experimental Psychology have shown that people who have had COVID but don’t complain of long COVID symptoms in daily life nevertheless can show degraded attention and memory for up to six to nine months.

New Academic Visitor from Nigeria

Associate Professor of Radiology, Godwin Ogbole has arrived on a six-month visit to the Nuffield Department of Clinical Neurosciences, as part of the Africa Oxford Initiative.

New spinout company: Human-Centric Drug Discovery

Human-Centric Drug Discovery is a new Oxford University spinout company from Professor Zameel Cader's lab.

Funding received for research into Motor Neuron Disease

A £210,000 donation from the Alan Davidson Foundation has been made to our Department to advance our world-leading research into Motor Neuron Disease. The funding will support a project manager to deliver an innovative research project using the genetic causes of MND to develop approaches to early diagnosis.

Research finds drug may benefit some patients hospitalised with COVID-19 pneumonia

A proof-of-concept trial involving Oxford researchers has identified a drug that may benefit some patients hospitalised with COVID-19 pneumonia.

Protein test could lead to earlier and better diagnosis of Parkinson’s

Scientists have observed the clumping of alpha-synuclein in the cerebrospinal fluid taken from people with Parkinson's. The findings offer hope that a pioneering new clinical test could be developed to diagnose Parkinson's correctly in its early stages.